Építés alatt – nem éles oldal
Belépés
Résztvevőt keres itt: KínaFázis nélkül

An Integrated Prenatal and Postnatal Treatment Model for the Treatment of Newborns With Critical Congenital Heart Disease

A legfontosabb adatok

Ki végzi
Beijing Anzhen Hospital
Hol
Beijing (Kína)A helyszín megnézése
Azonosító
Állapot
Toboroz
Résztvevők
10 000 fő, tervezett
Kezdés
2022. jan. 1.
Várható befejezés
2030. dec. 31.
A vizsgálat típusa
Megfigyeléses
A regiszteradat frissítve
2025. január 10.

Ki vehet részt

MI-összefoglaló

A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.

The trial is looking for newborns with critical congenital heart disease found by ultrasound before birth. The heart defect must be one that can be repaired so both heart pumping chambers work.

Életkor
1 day to 28 days
Nem
All
A betegség stádiuma
Critical congenital heart disease found by ultrasound at 22-26 weeks of pregnancy. It must be repairable with both heart pumping chambers working (biventricular repair). Full-term babies (37-40 weeks) or preterm babies born after more than 32 weeks but before 37 weeks can join. Birth weight must be > 1.5 kg (3 lb).

A részvétel fő kizáró okai

  • Babies who can only have palliative surgery (surgery that eases the problem without repairing it)
  • Babies who can only have single ventricle repair
  • Genetic or chromosome abnormalities
  • Other severe diseases affecting the whole body

A regiszter feltételei, szó szerint

Mind a 7 feltétel megnézéseKevesebb

Ki vehet részt

  • Full-term infants (gestational age 37-40 weeks): age less than 28 days
  • Preterm infants (gestational age greater than 32 weeks but less than 37 weeks): corrected gestational age as neonatal period, age less than 28 days
  • Birth weight > 1.5 kg
  • Fetal diagnosis of congenital heart diseases by ultrasound at 22-26 weeks of gestation, suitable for biventricular repair

Ki nem vehet részt

  • Only suitable for palliative surgery or single ventricle repair
  • Associated with other severe systemic diseases
  • Associated genetic/chromosomal abnormalities

Helyszínek itt: Kína

  • Biejing Anzhen HospitalBeijing, KínaContact: Lizhi Lv, MDRésztvevőt keres

A vizsgálatról

Mit akar kideríteni a vizsgálat

The purpose of this two-way cohort study was to explore whether an integrated prenatal and postnatal treatment model for neonates with critical congenital heart disease (CCHD) could be effective in avoiding preoperative morbidities, creating an ideal timing for surgery, thereby reducing postoperative in-hospital mortality, and improving surgical prognosis compared with the traditional model of care. In addition, in neonates with CCHD associated with the right cardiac system, the investigators aim to further investigate whether early postnatal cardiac surgery has the potential advantage of obtaining a time window for myocardial regeneration and thus improving myocardial remodeling. The aim of this study is to improve the diagnostic and therapeutic capacity of critical congenital heart disease and to promote the integrated prenatal-postnatal treatment model for clinical use. This will ultimately improve the quality of healthcare services for patients with cardiovascular diseases and lay the foundation for exploring guidelines for the treatment of cardiovascular diseases suitable for China's national conditions.

A teljes eredeti leírásKevesebb

The project will be jointly implemented by Beijing Anzhen Hospital , Capital Pediatric Research Institute, and 307 PLA General Hospital. Starting from January 1, 2022, the hospitals will continue to collect hospitalized cases of newborns with CCHD. The integrated prenatal and postnatal model is defined as a definitive diagnosis of CCHD in the fetal period (22-26 weeks), documentation of intrauterine transfer in our obstetrics department, subsequent initiation of an intrapartum or postpartum surgical plan after multidisciplinary consultation, and transfer to the pediatric heart center at the first hour of life, where the child is treated with either postpartum immediate or elective surgery, depending on patient status. For neonates who meet the indications for emergency surgery, surgery is performed immediately after birth. For neonates with non-emergency surgical indications, surgery is performed after birth adjustment to optimal status. The traditional model was defined as postpartum transfer via an outside hospital with routine interventions. The investigators then evaluate surgical prognosis and myocardial regenerative capacity to compare the effects of the two treatment models. This project will validate the advantages of an integrated prenatal and postnatal model over traditional models through real-world research and will improve prognosis in neonates with CCHD.

Kérdések a vizsgálat csapatának

  1. Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
  2. Megtérítik az utazási költséget?
  3. Megtarthatom a saját orvosomat?
  4. Mi történik, ha ki akarok lépni?

Contact the study team: see the registry record → Contacts and Locations

Oldal nyomtatása az orvosomnak

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
Hivatalos cím
Clinical Study of an Integrated Prenatal and Postnatal Treatment Model to Improve the Treatment Effect of Newborns With Critical Congenital Heart Disease
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
Publikációk
A regiszteradat frissítve
2025. január 10.